Brian C. Betts

2.1k total citations
68 papers, 1.2k citations indexed

About

Brian C. Betts is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Brian C. Betts has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 26 papers in Immunology and 22 papers in Oncology. Recurrent topics in Brian C. Betts's work include Hematopoietic Stem Cell Transplantation (40 papers), Immune Cell Function and Interaction (22 papers) and T-cell and B-cell Immunology (15 papers). Brian C. Betts is often cited by papers focused on Hematopoietic Stem Cell Transplantation (40 papers), Immune Cell Function and Interaction (22 papers) and T-cell and B-cell Immunology (15 papers). Brian C. Betts collaborates with scholars based in United States, Australia and China. Brian C. Betts's co-authors include Claudio Anasetti, Joseph Pidala, Xue‐Zhong Yu, Anandharaman Veerapathran, Bruce R. Blazar, James W. Young, Geoffrey R. Hill, David Bastian, Leslie S. Kean and Yongxia Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Brian C. Betts

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian C. Betts United States 21 614 578 390 196 151 68 1.2k
Elizabeth Rich United States 17 451 0.7× 681 1.2× 556 1.4× 202 1.0× 196 1.3× 56 1.2k
Zaid Al‐Kadhimi United States 18 337 0.5× 425 0.7× 540 1.4× 182 0.9× 108 0.7× 84 1.0k
Hirohito Yamazaki Japan 21 692 1.1× 1.0k 1.7× 251 0.6× 79 0.4× 240 1.6× 95 1.4k
Matteo Parma Italy 16 407 0.7× 477 0.8× 298 0.8× 136 0.7× 153 1.0× 39 954
Witold B. Rybka United States 21 797 1.3× 663 1.1× 676 1.7× 254 1.3× 182 1.2× 79 1.7k
Leo Luznik United States 22 910 1.5× 1.3k 2.2× 658 1.7× 237 1.2× 209 1.4× 60 1.8k
Fumihiko Ishimaru Japan 21 329 0.5× 358 0.6× 309 0.8× 249 1.3× 125 0.8× 93 1.1k
Alexandros Spyridonidis Greece 20 234 0.4× 594 1.0× 272 0.7× 281 1.4× 126 0.8× 75 1.1k
Attaphol Pawarode United States 17 229 0.4× 459 0.8× 244 0.6× 135 0.7× 81 0.5× 64 1.1k
Maria Rosa Motta Italy 18 480 0.8× 762 1.3× 469 1.2× 225 1.1× 176 1.2× 46 1.2k

Countries citing papers authored by Brian C. Betts

Since Specialization
Citations

This map shows the geographic impact of Brian C. Betts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian C. Betts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian C. Betts more than expected).

Fields of papers citing papers by Brian C. Betts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian C. Betts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian C. Betts. The network helps show where Brian C. Betts may publish in the future.

Co-authorship network of co-authors of Brian C. Betts

This figure shows the co-authorship network connecting the top 25 collaborators of Brian C. Betts. A scholar is included among the top collaborators of Brian C. Betts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian C. Betts. Brian C. Betts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pidala, Joseph, Shernan G. Holtan, Kelly Walton, et al.. (2023). JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Reduced Th1/Th17 Cells: Final Phase II Trial Results. Blood. 142(Supplement 1). 2177–2177. 1 indexed citations
2.
Beckman, Joan D., Elena L. Aronovich, Julia Nguyen, et al.. (2023). JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte–endothelial proadhesive interactions. Journal of Thrombosis and Haemostasis. 21(5). 1366–1380. 27 indexed citations
3.
Cao, Qing, Mark Juckett, Brian C. Betts, et al.. (2023). Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(4). 263.e1–263.e7. 7 indexed citations
4.
Jurdi, Najla El, Shernan G. Holtan, Benjamin Hillmann, et al.. (2023). Pre‐transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft‐versus‐host disease. British Journal of Haematology. 203(2). 288–294. 5 indexed citations
5.
Boucher, Justin C., Bishwas Shrestha, Mark B. Leick, et al.. (2023). Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia. Molecular Therapy — Oncolytics. 31. 100751–100751. 21 indexed citations
6.
Cao, Qing, Mark Juckett, Brian C. Betts, et al.. (2022). Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S424–S425.
7.
Miller, Daniel D., Todd E. DeFor, Bruce R. Blazar, et al.. (2022). High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease. Journal of Cutaneous Pathology. 49(6). 532–535. 3 indexed citations
8.
Jurdi, Najla El, Todd E. DeFor, Shernan G. Holtan, et al.. (2022). Predictors and outcomes of flares in chronic graft-versus-host disease. Bone Marrow Transplantation. 57(5). 790–794. 2 indexed citations
9.
Pidala, Joseph, Kelly Walton, Hany Elmariah, et al.. (2021). Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results. Clinical Cancer Research. 27(10). 2712–2722. 15 indexed citations
10.
11.
Perez, Lia, Hugo F. Fernández, Mohamed A. Kharfan‐Dabaja, et al.. (2021). A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention. Blood Advances. 5(13). 2740–2750. 9 indexed citations
12.
Weisdorf, Daniel J., John E. Wagner, Bruce R. Blazar, et al.. (2021). Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant. Bone Marrow Transplantation. 56(6). 1373–1380. 4 indexed citations
13.
Betts, Brian C. & James W. Young. (2020). Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019. Critical Care Explorations. 2(6). e0138–e0138. 5 indexed citations
14.
Holtan, Shernan G., Brian C. Betts, Armin Rashidi, et al.. (2019). Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease. JCI Insight. 4(17). 20 indexed citations
15.
Bastian, David, Yongxia Wu, Brian C. Betts, & Xue‐Zhong Yu. (2019). The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease. Frontiers in Immunology. 10. 988–988. 52 indexed citations
16.
Woods, David, Rupal Ramakrishnan, Andressa S. Laino, et al.. (2018). Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma. Clinical Cancer Research. 24(24). 6236–6247. 50 indexed citations
17.
MacDonald, Kelli P. A., Brian C. Betts, & Daniel R. Couriel. (2018). Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(3). S7–S14. 7 indexed citations
18.
Khimani, Farhad, Erin Dean, Brian C. Betts, et al.. (2017). Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention. Bone Marrow Transplantation. 52(7). 1003–1009. 8 indexed citations
19.
Curran, Shane A., Justin A. Shyer, Sneh Sharma, et al.. (2016). Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade. Cancer Immunology Research. 5(1). 52–60. 25 indexed citations
20.
Pidala, Joseph, Melissa Alsina, Brian C. Betts, et al.. (2015). Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease. Haematologica. 100(7). 970–977. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Rich Breakdown of academic impact, for papers by Zaid Al‐Kadhimi Breakdown of academic impact, for papers by Hirohito Yamazaki Breakdown of academic impact, for papers by Matteo Parma Breakdown of academic impact, for papers by Witold B. Rybka Breakdown of academic impact, for papers by Leo Luznik Breakdown of academic impact, for papers by Fumihiko Ishimaru Breakdown of academic impact, for papers by Alexandros Spyridonidis Breakdown of academic impact, for papers by Attaphol Pawarode Breakdown of academic impact, for papers by Maria Rosa Motta
Rankless by CCL
2026